Ligand validation:3BPO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3BPO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BPO_NAG_B_901	9%	5%	0.255	0.752	2.66	2.63	4	6	2	1	100%	0.9333
8K4Q_NAG_C_302	29%	57%	0.21	0.87	0.36	1.27	-	1	0	0	100%	0.9333
3BPN_NAG_B_901	23%	52%	0.172	0.791	0.84	1.02	-	2	0	0	100%	0.9333
5E4E_NAG_B_302	18%	73%	0.25	0.838	0.31	0.71	-	-	0	0	100%	0.9333
3BPL_NAG_C_931	14%	71%	0.256	0.811	0.45	0.67	-	-	0	0	100%	0.9333
6WGL_NAG_C_301	14%	19%	0.27	0.824	0.89	2.5	1	5	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.